Actively Recruiting
Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics
Led by University of Monastir · Updated on 2023-11-14
500
Participants Needed
1
Research Sites
230 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this subject. The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency department after the first line treatment of a renal colic investigating the reccurence of pain, the reconsultation rates and the admissions.
CONDITIONS
Official Title
Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years old
- Consenting to participate in the study
- Patients treated in the ED for renal colic
- No contraindications of NSAI or paracetamol treatment
You will not qualify if you...
- Contraindication of NSAI treatment
- Patients not reachable by telephone call
- Patients that did not receive or use the treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fattouma Bourguiba University Hospital
Monastir, Tunisia, 5000
Actively Recruiting
Research Team
N
Nouira semir, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here